South Miami, FLNCT06888193Now EnrollingIRB Ready

Moderate to Severe Plaque Psoriasis Clinical Trial in South Miami, FL

Access cutting-edge moderate to severe plaque psoriasis treatment through this clinical trial at a research site in South Miami. Study-provided care at no cost to qualified participants.

Sponsored by UCB Biopharma SRL

Quick Self-Assessment

See if you qualify for this South Miami location

Preparing your pre-screening questions…

Expert Care in South Miami

Access moderate to severe plaque psoriasis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related moderate to severe plaque psoriasis treatment provided free

Apply for This South Miami Location

Check if you qualify for this moderate to severe plaque psoriasis clinical trial in South Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to South Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit South Miami site if eligible
  4. 4Begin participation

About This Moderate to Severe Plaque Psoriasis Study in South Miami

Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

Sponsor: UCB Biopharma SRL

Who Can Participate

Inclusion Criteria

Study participant must be at least 18 years of age at the time of signing the informed consent.
Study participant is being treated with commercial bimekizumab per locally approved prescribing information and in accordance with her treating physician.
Study participant is breastfeeding and intends to breastfeed throughout the Sampling Period.
The decision to treat with bimekizumab and to breastfeed is made independently from and prior to the study participant consenting to participate in the study.
Study participant must be on bimekizumab treatment for at least 12 weeks after delivery and since starting/restarting/continuing bimekizumab prior to sampling (prior to start of the Sampling Period).
A female study participant is eligible to participate if she is not pregnant and does not plan to become pregnant during the study.

Exclusion Criteria

Study participant has any medical, obstetrical, or psychiatric condition that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study.
The infant has any abnormality noted on physical examination or medical history that, in the opinion of the Investigator, may jeopardize or compromise study participation.
Study participant has a history of chronic alcohol or drug abuse within the previous last year.
Study participant has history of breast implants, breast augmentation, or breast reduction surgery.
Study participant plans a surgical intervention during the Screening Period and Sampling Period or anticipates having surgery while participating in the Sampling Period (does not apply to tubal ligation).
Study participant or her infant has participated in another study of an investigational medicinal product (IMP) (and/or an investigational device) within the previous 6 months or is currently participating in another study of an IMP (and/or an investigational device), unless the study is UCB PS0036 or a bimekizumab registry study.
Study participant or her infant has previously participated (ie, entered the sampling period) in this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in South Miami?

Yes, this clinical trial (NCT06888193) has an active research site in South Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Moderate to Severe Plaque Psoriasis Treatment Options in South Miami, FL

If you're searching for moderate to severe plaque psoriasis treatment options in South Miami, FL, this clinical trial (NCT06888193) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our South Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced moderate to severe plaque psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all moderate to severe plaque psoriasis clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in South Miami, FL

See all rheumatoid arthritis clinical trials recruiting in South Miami — not just this study.

Browse Rheumatoid Arthritis Trials in South Miami

Ready to Join in South Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · South Miami, FL